ACSTRYKE
Live / Applied — First extension granted (statement of use) (as of 04 Feb 2026)
What this means for you
Not registered yet, but its 03 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99026607
- Mark type
- Stylized text
- Filed
- 03 Feb 2025
- Published for opposition
- 01 Jul 2025
- Attorney of record
- Xiomara Triana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; diagnostic radiopharmaceutical preparations.
Owner
- RayzeBio, Inc., San Diego, CA, US
- RayzeBio, Inc., San Diego, CA, US
Prosecution history
- 04 Feb 2026 — SOU EXTENSION 1 GRANTED
- 04 Feb 2026 — SOU EXTENSION 1 FILED
- 04 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jul 2025 — PUBLISHED FOR OPPOSITION
- 25 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 May 2025 — ASSIGNED TO EXAMINER
- 03 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 03 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Feb 2025 — NEW APPLICATION ENTERED